Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Reports 51-Percent Drop in Revenue, Nearly Doubled Loss for Q4 2004

NEW YORK, Feb. 23 (GenomeWeb News) - Nanogen today reported a 51-percent slide in revenues and an 89-percent increase in its net losses for the fourth quarter of 2004.

The company had slightly more than $1 million in total revenues, down from $2.1 million during the same quarter in 2003. Product revenues were $410,000 for the fourth quarter of 2004, compared to $1.1 million for the prior-year period.

R&D costs for Q4 2004 were $5.2 million, a $700,000 increase in spending from $4.5 million during the same period a year ago.

Nanogen's net loss for the quarter amounted to $11.2 million, or $.31 per share, compared to a net loss of $5.9 million, or $.25 per share, during the fourth quarter of 2003.  

As of Dec. 31, Nanogen had a cash position of $51.9 million. Of that, $15.4 million is in the form of cash and cash equivalents, with the remainder in the form of short-term investments.

The firm's cash holdings benefitted from a $5.7 million cash infusion after it acquired Epoch Biosciences for $97 million in December 2004.

Howard Birndoff, Nanogen's CEO and chairman of the board, said in a statement that his company plans to increase revenues in 2005 by launching three new products that will be based on the product portfolios the company gained following the merger with Epoch, and an April 2004 merger with SynX.

Birndoff said he expected total revenue for 2005 would increase three-fold as compared to 2004.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.